Jagsonpal Pharmaceuticals Ltd.

Financial

	Jagsonpal Pharma	Bliss GVS Pharma	Beta Drugs
Operational Metrics
Financials
5 yr Average ROE	12.82 %	6.83 %	21.73 %
5yr average Equity Multiplier	1.29	1.3	1.75
5yr Average Asset Turnover Ratio	1.12	0.62	1.04
5yr Avg Net Profit Margin	8.95 %	8.7 %	11.97 %
Price to Book	7.52	1.75	0.0
P/E	29.67	17.2	41.17
5yr Avg Cash Conversion Cycle	-0.27 Days	186.56 Days	15.7 Days
Inventory Days	47.66 Days	54.35 Days	43.83 Days
Days Receivable	25.88 Days	189.93 Days	87.61 Days
Days Payable	68.7 Days	75.78 Days	113.94 Days
5yr Average Interest Coverage Ratio	56.07	14.68	13.71
5yr Avg ROCE	17.0 %	13.27 %	27.85 %
5yr Avg Operating Profit Margin	10.5 %	17.03 %	21.58 %
5 yr average Debt to Equity	0.02	0.11	0.23
5yr CAGR Net Profit	23.34 %	4.24 %	31.07 %
5yr Average Return on Assets	9.97 %	5.31 %	12.53 %
Shareholdings
Promoter Holding	67.65 %	35.44 %	66.73 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-1.06 %	0.93 %	0.02 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Jagsonpal Pharma	Bliss GVS Pharma	Beta Drugs
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 100.0 Anti Inflammatory 0 Anti-biotic 0 Anti-bacterial 0 Anti-fungal, 0 Antimalarial 0 Manufacturing of Oncology medicines 0	Product Wise Break-Up Antibiotics 5.0 Anti Inflammatory 7.0 Anti-bacterial 0 Anti Malarials 43.0 Anti-fungal 16.0 Manufacturing of Oncology medicines 0 Pharmaceuticals 0 Others 29.0	Product Wise Break-Up Anti-biotic 0 Anti Inflammatory 0 Anti-bacterial 0 Antimalarial 0 Anti-fungal, 0 Oncology 100.0 Pharmaceuticals 0
Location Wise Break-Up	Location Wise Break-Up India 97.77 Rest of the World 0 India 0 Others 2.23	Location Wise Break-Up Rest of the World 93.39 India 6.61	Location Wise Break-Up Rest of the World 0 India 0 Others 100